Optiver Holding
ANIP icon

Optiver Holding’s ANI Pharmaceuticals ANIP Stock Holding History

Optiver Holding’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.29K Buy
+88
New +$7.06K ﹤0.01% 1841
2025
Q4 		– Sell
-120
Closed -$11K – 2477
2025
Q3 		$11K Buy
+120
New +$9.79K ﹤0.01% 1237

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Optiver Holding's ANIP Position: Q2 2026 in Review

Optiver Holding opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 88 shares worth $7.29K. The stake represents ﹤0.01% of the portfolio and ranks #1841 among its holdings. This is a return to the name: Optiver Holding previously reported a position in ANIP as recently as Q3 2025.

Optiver Holding first reported a position in ANIP in Q3 2025 and has held it in 2 quarters since. The position peaked at $11K in Q3 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Optiver Holding held 88 shares of ANI Pharmaceuticals worth $7.29K as of Q2 2026.
  • ANI Pharmaceuticals was a new Optiver Holding position in Q2 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1841 holding.
  • Optiver Holding first reported a position in ANI Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • Optiver Holding's ANI Pharmaceuticals position peaked at $11K in Q3 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.